Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 25, 2016 08:30 ET | Source: Akorn, Inc.

Akorn Relaunches Ofloxacin Otic Solution

LAKE FOREST, Ill., Aug. 25, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has relaunched Ofloxacin Otic Solution 0.3%, a...
August 24, 2016 08:30 ET | Source: Akorn, Inc.

Akorn to Present at Morgan Stanley Global Healthcare Conference

LAKE FOREST, Ill., Aug. 24, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Akorn’s CEO, Raj Rai, will participate in a...
August 18, 2016 08:30 ET | Source: Akorn, Inc.

Akorn Appoints Robert Monahan as Senior Vice President of Corporate Development

LAKE FOREST, Ill., Aug. 18, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Rob Monahan has recently joined Akorn as...
August 04, 2016 07:00 ET | Source: Akorn, Inc.

Akorn Provides Second Quarter 2016 Results

- Q2 2016 Revenue Increase of 27% to $281 Million -- Q2 2016 GAAP EPS Increase of 85% to $0.50; Adjusted Q2 2016 EPS Increase of 41% to $0.58 -- Updates 2016 Revenue and EPS Guidance -- Board of...
July 21, 2016 08:05 ET | Source: Akorn, Inc.

Akorn Announces Second Quarter 2016 Earnings Release and Conference Call Information

LAKE FOREST, Ill., July 21, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release on...
June 02, 2016 06:30 ET | Source: Akorn, Inc.

Akorn Updates Form S-8 Status by Filing Form 10-Q’s for First, Second and Third Quarters of 2015

LAKE FOREST, Ill., June 02, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it has filed quarterly reports on Forms 10-Q...
May 31, 2016 08:30 ET | Source: Akorn, Inc.

Akorn to Present at Two Upcoming Investor Conferences

LAKE FOREST, Ill., May 31, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that management will be presenting at the Jefferies...
May 16, 2016 16:42 ET | Source: Akorn, Inc.

Akorn Provides First Quarter 2016 Results

- Q1 2016 GAAP Revenue of $268 million - - GAAP EPS of $0.34; Adjusted Q1 2016 EPS of $0.54 - - Conference Call and Webcast to Be Held May 17, 2016 at 10:00 a.m. EDT - LAKE FOREST, Ill., May 16,...
May 10, 2016 06:44 ET | Source: Akorn, Inc.

Akorn Completes 2014 Financial Statement Restatement and Reports Audited 2015 and Restated 2014 Results

- Sets Date for 2016 Annual Meeting - Affirms 2016 Net Revenue and Earnings per Share Guidance LAKE FOREST, Ill., May 10, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty...
May 06, 2016 14:50 ET | Source: Akorn, Inc.

Akorn Outlines Timeline for 2015 Form 10-K Filing, First Quarter 2016 Form 10-Q Filing and Investor Conference Calls

LAKE FOREST, Ill., May 06, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced the target dates for upcoming filings and press...